Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings
- PMID: 10972241
- DOI: 10.1089/089771500415391
Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings
Abstract
This study was designed to investigate the correlation between S-100 protein serum measurements and neuroradiological findings in patients with head injury. We studied 278 patients with minor, moderate, and severe head injuries and 110 controls with no history of neurological disease. The study recruited patients from three Scandinavian neurotrauma centers. Serum levels of S-100 protein were measured at admittance, and computed tomographic scans of the brain were obtained within 24 h postinjury in all patients. In a subgroup of 45 patients with minor head injuries, magnetic resonance imaging was also performed. Increased serum level of S-100 protein was detected in 108 (39%) patients, and CT scan demonstrated intracranial pathology in 25 (9%) (brain contusion n = 13, subdural hematoma n = 6, epidural hematoma n = 2, traumatic subarachnoid hemorrhage n = 2, and brain edema n = 2). The proportion of patients with detectable serum level was significantly (p < 0.01) higher among those with intracranial pathology (92%) compared to those without (34%). The negative predictive value of an undetectable S-100 serum level was 0.99. Undetectable serum level of S-100 protein predicts normal intracranial findings on CT scan. Determination of S-100 protein in serum may be used to select patients for CT scanning.
Similar articles
-
The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study.Brain Inj. 2000 Dec;14(12):1047-55. doi: 10.1080/02699050050203540. Brain Inj. 2000. PMID: 11147577
-
Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome.Neurosurgery. 1999 Sep;45(3):468-75; discussion 475-6. doi: 10.1097/00006123-199909000-00010. Neurosurgery. 1999. PMID: 10493368
-
[Can serum protein S100beta predict neurological deterioration after moderate or minor traumatic brain injury?].Ann Fr Anesth Reanim. 2009 Feb;28(2):135-9. doi: 10.1016/j.annfar.2008.12.019. Epub 2009 Feb 10. Ann Fr Anesth Reanim. 2009. PMID: 19211218 French.
-
Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.Neurosurg Focus. 2010 Nov;29(5):E2. doi: 10.3171/2010.8.FOCUS10185. Neurosurg Focus. 2010. PMID: 21039136 Review.
-
Serum S-100B protein as a molecular marker in severe traumatic brain injury.Restor Neurol Neurosci. 2003;21(3-4):159-69. Restor Neurol Neurosci. 2003. PMID: 14530578 Review.
Cited by
-
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.BMC Cancer. 2016 Jul 7;16:428. doi: 10.1186/s12885-016-2448-1. BMC Cancer. 2016. PMID: 27387327 Free PMC article.
-
Current Trends in Biomarkers for Traumatic Brain Injury.Open Access J Neurol Neurosurg. 2020;12(4):86-94. Epub 2020 Jan 8. Open Access J Neurol Neurosurg. 2020. PMID: 32775958 Free PMC article.
-
αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.J Neurotrauma. 2010 Jul;27(7):1203-13. doi: 10.1089/neu.2010.1278. J Neurotrauma. 2010. PMID: 20408766 Free PMC article.
-
Update on benign convulsions with mild gastroenteritis.Clin Exp Pediatr. 2022 Oct;65(10):469-475. doi: 10.3345/cep.2021.00997. Epub 2021 Dec 27. Clin Exp Pediatr. 2022. PMID: 34961297 Free PMC article.
-
Mild Traumatic Brain Injury among the Geriatric Population.Curr Transl Geriatr Exp Gerontol Rep. 2012 Sep 1;1(3):135-142. doi: 10.1007/s13670-012-0019-0. Curr Transl Geriatr Exp Gerontol Rep. 2012. PMID: 23589783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources